WVE
Wave Life Sciences Ltd.
$7.18
-0.83%
2026-05-08
About Wave Life Sciences Ltd.
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-008, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of liver disease; WVE-N531, an exon splicing oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Key Fundamentals
Forward P/E
-6.48
EPS (TTM)
$-1.05
ROE
-53.1%
Revenue Growth (YoY)
316.9%
Profit Margin
-255.7%
Debt/Equity
3.07
Price/Book
2.60
Beta
-1.32
Market Cap
$1.38B
Avg Volume (10D)
4.4M
Recent Breakout Signals
No recent breakout signals detected for WVE.
Recent Price Range (60 Days)
60D High
$15.47
60D Low
$5.02
Avg Volume
4.3M
Latest Close
$7.18
Get breakout alerts for WVE
Sign up for Breakout Scanner to receive daily notifications when WVE triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Wave Life Sciences Ltd. (WVE) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors WVE daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. WVE operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.